Kelly Habbas reports 21.5% stake in WORK (NASDAQ: WOK)

Rhea-AI Filing Summary

WORK Medical Technology Group LTD disclosure: Kelly Habbas beneficially owns 369,000 Class A Ordinary Shares, representing 21.5% of the class, and reports sole voting and sole dispositive power over those shares. The filing is dated 06/10/2026.

Key Figures

Filing date: 06/10/2026 Shares beneficially owned: 369,000 shares Percent of class: 21.5%

3 metrics

Filing date 06/10/2026 Schedule 13G/A amendment date

Shares beneficially owned 369,000 shares Class A Ordinary Shares reported by Kelly Habbas

Percent of class 21.5% Percentage of Class A Ordinary Shares beneficially owned

Key Terms

Schedule 13G/A, Beneficially owned, Sole dispositive power

3 terms

Schedule 13G/A regulatory

"Amendment No. 1 and header identifying the filing as SCHEDULE 13G/A"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficially owned financial

"Item 4(a) Amount beneficially owned: 369,000"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole dispositive power regulatory

"Item 4(c)(iii) Sole power to dispose or to direct the disposition of: 369,000"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

WORK Medical Technology Group LTD

(Name of Issuer)

Class A Ordinary Shares

(Title of Class of Securities)

G9767H125

(CUSIP Number)

06/10/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): G9767H125

1

Names of Reporting Persons

Habbas Kelly Khalid

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 369,000.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 369,000.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

369,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

21.5 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: WORK Medical Technology Group LTD
(b)	Address of issuer's principal executive offices: 1/88 COOK ST, 1/88 COOK ST, AUCKLAND CITY, NEW ZEALAND, 1001
Item 2.
(a)	Name of person filing: Kelly Habbas
(b)	Address or principal business office or, if none, residence: 15068 Mountain View Lane Frisco, TX 75035
(c)	Citizenship: United States
(d)	Title of class of securities: Class A Ordinary Shares
(e)	CUSIP No.: G9767H125
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 369,000
(b)	Percent of class: 21.5 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 369,000
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 369,000
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Habbas Kelly Khalid

Signature:	Kelly Habbas
Name/Title:	Investor
Date:	06/10/2026

FAQ

What stake does Kelly Habbas report in WORK (WOK)?

Kelly Habbas reports beneficial ownership of 369,000 Class A Ordinary Shares, which equals 21.5% of the outstanding Class A shares, with sole voting and dispositive power as of 06/10/2026.

What does "sole dispositive power" mean in this 13G/A filing?

"Sole dispositive power" means the filer has exclusive authority to decide whether to sell or transfer the shares. The filing states Kelly Habbas holds sole power to dispose of the 369,000 shares reported on 06/10/2026.

Is this a Schedule 13G/A or a Schedule 13D and why does it matter?

The document is a Schedule 13G/A, an amendment to a passive/large-holder disclosure. It notifies the market of beneficial ownership rather than indicating an active acquisition strategy or takeover intent.

Does the filing show shared voting or dispositive power?

No. The filing lists 0 shares for shared voting power and 0 for shared dispositive power; it reports 369,000 shares under sole voting and sole dispositive power as of 06/10/2026.

Where is WORK Medical Technology Group LTD's principal office listed in the filing?

The filing lists the issuer's principal executive office as 1/88 COOK ST, AUCKLAND CITY, NEW ZEALAND, 1001 in the provided disclosure.